Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.

Tytuł:
Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.
Autorzy:
Brown T; Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA .; Center for Communicable Disease Dynamics, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
de Salazar Munoz PM; Center for Communicable Disease Dynamics, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.
Bhatia A; François-Xavier Bagnoud Center for Health and Human Rights, Harvard University, Boston, Massachusetts, USA.
Bunda B; Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Williams EK; Massachusetts General Hospital, Boston, MA, USA.
Bor D; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Cambridge Health Alliance, Cambridge, Massachusetts, USA.
Miller JS; Global Medicine Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mohareb A; Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Thierauf J; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Yang W; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Villalba J; Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Naranbai V; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Garcia Beltran W; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Miller TE; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kress D; City of Somerville, Somerville, Massachusetts, USA.
Stelljes K; City of Somerville, Somerville, Massachusetts, USA.
Johnson K; City of Somerville, Somerville, Massachusetts, USA.
Larremore D; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Lennerz J; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Iafrate AJ; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Balsari S; Harvard Medical School, Boston, Massachusetts, USA.; François-Xavier Bagnoud Center for Health and Human Rights, Harvard University, Boston, Massachusetts, USA.
Buckee C; Center for Communicable Disease Dynamics, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.
Grad Y; Center for Communicable Disease Dynamics, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Źródło:
BMJ open [BMJ Open] 2023 Mar 07; Vol. 13 (3), pp. e061840. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
MeSH Terms:
COVID-19*/epidemiology
Humans ; SARS-CoV-2 ; Cross-Sectional Studies ; Seroepidemiologic Studies ; Computer Simulation
References:
Health Educ Behav. 2020 Aug;47(4):509-513. (PMID: 32436405)
J Epidemiol Community Health. 2022 Jan;76(1):1-7. (PMID: 34158409)
Biostatistics. 2015 Jul;16(3):565-79. (PMID: 25597489)
Public Health Rep. 2001;116 Suppl 1:216-22. (PMID: 11889287)
J Prev Med Public Health. 2020 Jul;53(4):220-227. (PMID: 32752590)
JAMA Intern Med. 2020 Jul 21;:. (PMID: 32692365)
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1100-1101. (PMID: 32790658)
N C Med J. 2004 Nov-Dec;65(6):385-7. (PMID: 15714732)
Emerg Infect Dis. 2021 Nov;27(1):. (PMID: 33171096)
Nat Commun. 2020 Sep 16;11(1):4674. (PMID: 32938924)
Ethn Dis. 2005 Summer;15(3):395-406. (PMID: 16108298)
Int J Epidemiol. 2021 May 17;50(2):410-419. (PMID: 33615345)
J Urban Health. 2020 Aug;97(4):461-470. (PMID: 32691212)
JAMA Netw Open. 2021 Feb 1;4(2):e2037067. (PMID: 33560423)
Public Health Rep. 2022 Jan-Feb;137(1):128-136. (PMID: 34752156)
New Dir Child Adolesc Dev. 2013 Fall;2013(141):43-60. (PMID: 24038806)
PLoS One. 2020 Apr 28;15(4):e0232452. (PMID: 32343747)
J Gen Intern Med. 2021 Jul;36(7):2130-2133. (PMID: 33754319)
Clin Infect Dis. 2021 Nov 2;73(9):e3120-e3123. (PMID: 33300579)
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):312-315. (PMID: 33661862)
Ann Epidemiol. 2020 Aug;48:23-29.e4. (PMID: 32648546)
Elife. 2021 Mar 05;10:. (PMID: 33666169)
J Infect Dis. 2020 Nov 13;222(12):1955-1959. (PMID: 32906151)
Emerg Infect Dis. 2020 Nov;26(11):2766-2769. (PMID: 32731911)
Vaccine. 2002 Aug 19;20(25-26):3130-6. (PMID: 12163264)
J Infect Dis. 2020 Sep 1;222(7):1086-1089. (PMID: 32750135)
Grant Information:
T32 AI007061 United States AI NIAID NIH HHS; T32 AI007433 United States AI NIAID NIH HHS; T32 AI007535 United States AI NIAID NIH HHS; U01 CA261277 United States CA NCI NIH HHS
Contributed Indexing:
Keywords: COVID-19; epidemiology; information technology; public health; statistics & research methods
Entry Date(s):
Date Created: 20230307 Date Completed: 20230309 Latest Revision: 20240415
Update Code:
20240415
PubMed Central ID:
PMC10008195
DOI:
10.1136/bmjopen-2022-061840
PMID:
36882240
Czasopismo naukowe
Objectives: Convenience sampling is an imperfect but important tool for seroprevalence studies. For COVID-19, local geographic variation in cases or vaccination can confound studies that rely on the geographically skewed recruitment inherent to convenience sampling. The objectives of this study were: (1) quantifying how geographically skewed recruitment influences SARS-CoV-2 seroprevalence estimates obtained via convenience sampling and (2) developing new methods that employ Global Positioning System (GPS)-derived foot traffic data to measure and minimise bias and uncertainty due to geographically skewed recruitment.
Design: We used data from a local convenience-sampled seroprevalence study to map the geographic distribution of study participants' reported home locations and compared this to the geographic distribution of reported COVID-19 cases across the study catchment area. Using a numerical simulation, we quantified bias and uncertainty in SARS-CoV-2 seroprevalence estimates obtained using different geographically skewed recruitment scenarios. We employed GPS-derived foot traffic data to estimate the geographic distribution of participants for different recruitment locations and used this data to identify recruitment locations that minimise bias and uncertainty in resulting seroprevalence estimates.
Results: The geographic distribution of participants in convenience-sampled seroprevalence surveys can be strongly skewed towards individuals living near the study recruitment location. Uncertainty in seroprevalence estimates increased when neighbourhoods with higher disease burden or larger populations were undersampled. Failure to account for undersampling or oversampling across neighbourhoods also resulted in biased seroprevalence estimates. GPS-derived foot traffic data correlated with the geographic distribution of serosurveillance study participants.
Conclusions: Local geographic variation in seropositivity is an important concern in SARS-CoV-2 serosurveillance studies that rely on geographically skewed recruitment strategies. Using GPS-derived foot traffic data to select recruitment sites and recording participants' home locations can improve study design and interpretation.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies